Fushimi T, Okayama H, Seki T, Shimura S, Shirato K
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Int Arch Allergy Immunol. 1997 Jan;112(1):13-8. doi: 10.1159/000237425.
Interleukin-10 (IL-10) is known to inhibit T cell-mediated responses. IL-10 has also been shown to play an important pathogenetic role in allergic diseases. Glucocorticoid is known to inhibit the production and gene expression of many cytokines which induce inflammatory reactions. We examined the effect of dexamethasone on the gene expression and production of IL-10 by human peripheral blood mononuclear cells (PBMCs) and monocytes. PBMCs and monocytes from 5 healthy volunteers were incubated with or without dexamethasone for 1 h, then stimulated with 5 micrograms/ml lipopolysaccharide (LPS). Gene expression and production of IL-10 by human PBMCs were detected without stimulation and increased by LPS stimulation. Dexamethasone suppressed the gene expression and production of IL-10 by LPS-stimulated PBMCs in a dose-dependent manner by 41.6 and 61.1% at 10(-6) M, respectively. Also in monocytes, the gene expression and production of IL-10 were detected without stimulation, increased by LPS stimulation, and significantly suppressed by dexamethasone by 53.1 and 61.2% at 10(-6) M, respectively. This suppressive effect on IL-10 gene expression was not so potent compared with its effect on cytokines such as IL-5. The suppression of IL-10 production by glucocorticoid is suggested to be one of the important mechanisms by which glucocorticoids suppress allergic inflammation in the treatment of allergic diseases.
白细胞介素-10(IL-10)已知可抑制T细胞介导的反应。IL-10在过敏性疾病中也已显示出重要的致病作用。已知糖皮质激素可抑制许多诱导炎症反应的细胞因子的产生和基因表达。我们研究了地塞米松对人外周血单个核细胞(PBMC)和单核细胞中IL-10基因表达及产生的影响。将5名健康志愿者的PBMC和单核细胞在有或无地塞米松的情况下孵育1小时,然后用5微克/毫升脂多糖(LPS)刺激。未刺激时可检测到人PBMC中IL-10的基因表达及产生,LPS刺激后其表达和产生增加。地塞米松以剂量依赖的方式抑制LPS刺激的PBMC中IL-10的基因表达及产生,在10^(-6) M时分别抑制41.6%和61.1%。同样在单核细胞中,未刺激时可检测到IL-10的基因表达及产生,LPS刺激后增加,地塞米松在10^(-6) M时分别显著抑制53.1%和61.2%。与它对诸如IL-5等细胞因子的作用相比,这种对IL-10基因表达的抑制作用没那么强。糖皮质激素对IL-10产生的抑制作用被认为是糖皮质激素在治疗过敏性疾病时抑制过敏性炎症的重要机制之一。